Sanna Bastiano - SEC Form 4 Insider Trading Screener

General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
15 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-05-05
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$350.00-3,27232,038-9%-$1,145,213
M
2023-05-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$350.71-4,40335,310-11%-$1,544,187
2023-04-12
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$326.70-7,56739,713-16%-$2,472,164
2023-04-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$315.81-52247,280-1%-$164,854
2023-03-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.59-2,74649,268-5%-$825,423
2023-02-14
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.40-2,18159,734-4%-$655,161
2023-02-13
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.39-11361,9150%-$33,944
2023-01-31
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$325.00-10637,9980%-$34,450
2022-11-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$312.64-32038,104-1%-$100,045
2022-10-18
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.31-1,79139,192-4%-$537,860
2022-05-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$252.83-4541,7490%-$11,377
2022-05-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$275.09-3641,6600%-$9,903
2022-05-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$259.16-32041,696-1%-$82,930
2022-04-07
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$276.18-56142,782-1%-$154,935
M
2022-04-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$274.10-3,72543,343-8%-$1,021,005

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top